Evidence map›Paper›PMID 34436670›Full record

ArticleHuman genetics2021

Complete lung agenesis caused by complex genomic rearrangements with neo-TAD formation at the SHH locus.

Uirá Souto Melo, Juliette Piard, Björn Fischer-Zirnsak, Marius-Konstantin Klever, Robert Schöpflin, Martin Atta Mensah, Manuel Holtgrewe, Francine Arbez-Gindre, Alain Martin, Virginie Guigue and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. HYENA detects oncogenes activated by distal enhancers in cancer.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Uirá Souto Melo *Max Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany.
Juliette Piard *Centre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
Björn Fischer-ZirnsakInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Marius-Konstantin KleverMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany.
Robert SchöpflinMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany.
Martin Atta MensahInstitute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Manuel HoltgreweBerlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Francine Arbez-GindreDepartments of Obstetrics and Gynecology, Pathology, and Biology, University Hospital, University of Franche-Comte, Besançon, France.
Alain MartinDepartments of Obstetrics and Gynecology, Pathology, and Biology, University Hospital, University of Franche-Comte, Besançon, France.
Virginie GuigueDepartments of Obstetrics and Gynecology, Pathology, and Biology, University Hospital, University of Franche-Comte, Besançon, France.
Dominique GaillardDepartment of Obstetrics and Gynecology, University Hospital Grenoble-Alpes, Grenoble, France.
Emilie LandaisDepartment of Obstetrics and Gynecology, University Hospital Grenoble-Alpes, Grenoble, France.
Virginie RozeDepartments of Obstetrics and Gynecology, Pathology, and Biology, University Hospital, University of Franche-Comte, Besançon, France.
Valerie KremerDepartment of Medical Genetics, University Hospital, University Champagne-Ardennes, Reims, France.
Rajeev RamanahDepartments of Obstetrics and Gynecology, Pathology, and Biology, University Hospital, University of Franche-Comte, Besançon, France.
Christelle CabrolCentre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
Frederike L HarmsInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Uwe KornakInstitute of Human Genetics, Universitätsmedizin Göttingen, Göttingen, Germany.
Malte SpielmannMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany.
Stefan MundlosMax Planck Institute for Molecular Genetics, RG Development and Disease, Berlin, Germany. stefan.mundlos@charite.de.
Lionel Van MaldergemCentre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
Université de franche-comté · FRHumboldt-Universität zu Berlin · DECentre Hospitalier Universitaire de Grenoble · FRMax Planck Institute for Molecular Genetics · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEInserm · FRUniversität Hamburg · DEUniversitätsmedizin Göttingen · DEUniversity Hospital of Geneva · CH

Funding

Deutsche Forschungsgemeinschaft KU 1240/10-1Deutsche Forschungsgemeinschaft MU 880/16-1Deutsche Forschungsgemeinschaft SP1532/3-1Deutsche Forschungsgemeinschaft SP1532/5-1
6 · The paper itself

Abstract

During human organogenesis, lung development is a timely and tightly regulated developmental process under the control of a large number of signaling molecules. Understanding how genetic variants can disturb normal lung development causing different lung malformations is a major goal for dissecting molecular mechanisms during embryogenesis. Here, through exome sequencing (ES), array CGH, genome sequencing (GS) and Hi-C, we aimed at elucidating the molecular basis of bilateral isolated lung agenesis in three fetuses born to a non-consanguineous family. We detected a complex genomic rearrangement containing duplicated, triplicated and deleted fragments involving the SHH locus in fetuses presenting complete agenesis of both lungs and near-complete agenesis of the trachea, diagnosed by ultrasound screening and confirmed at autopsy following termination. The rearrangement did not include SHH itself, but several regulatory elements for lung development, such as MACS1, a major SHH lung enhancer, and the neighboring genes MNX1 and NOM1. The rearrangement incorporated parts of two topologically associating domains (TADs) including their boundaries. Hi-C of cells from one of the affected fetuses showed the formation of two novel TADs each containing SHH enhancers and the MNX1 and NOM1 genes. Hi-C together with GS indicate that the new 3D conformation is likely causative for this condition by an inappropriate activation of MNX1 included in the neo-TADs by MACS1 enhancer, further highlighting the importance of the 3D chromatin conformation in human disease.

Indexed as

Evolution, MolecularAbnormalities, MultipleAdultCadaverFemaleFetusGenetic VariationGenome, HumanHumansLungLung DiseasesMaleOrganogenesisPregnancy

Identifiers

PMID34436670
PMCPMC8460539
OpenAlexW3194426156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.